Treating Self-criticism in Adolescents: a Study With Single-case Experimental Design

October 25, 2024 updated by: Maria Zetterqvist, Region Östergötland
In this pilot study, the effect of a group intervention targeting self-criticism in adolescents in a clinical child- and adolescent psychiatric outpatient setting will be examined using a single-case experimental design (AB). Participants will be randomized to multiple baseline with weekly measures. Our primary outcomes, measured weekly, are self-criticism, nonsuicidal self-injury and symptoms of depression and anxiety, as well as an individually chosen behavior driven by self-criticism. Secondary outcomes are self-compassion, psychological flexibility, quality of life and functioning. In addition to the weekly administered questionnaires, before and after measures, and 3- and 6-month follow-up will be collected. After the treatment, participants will also be interviewed about their experiences of targeting self-criticism.

Study Overview

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linköping, Sweden, 581 85
        • Region Östergötland BUP-kliniken

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient at the child- and adolescent psychiatric clinic in Linköping, Sweden.
  • 15 to 18 years
  • an adequate understanding of the Swedish language
  • cognitively capable of giving informed consent
  • scoring 26 or above on subscale "Inadequate self" and 8.5 or above on subscale "Hated Self" on questionnaire Forms of Self-Criticism and Self-Reassuring Scale (FSCRS)
  • the treatment is transdiagnostic so all diagnoses are included (See exclusion criteria for exceptions).

Exclusion Criteria:

  • severe anorexia, BMI ≤ 16
  • ongoing substance abuse
  • diagnosed intellectual disability
  • needing interpreter for translation of Swedish language
  • participants who cannot give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treating self-criticism
8-session group intervention targeting self-criticism given 2-hrs/week with booster session after 3-months.
A psychological treatment given i a group format targeting self-criticism. The treatment is based on treatment principles from Cognitive behavior therapy, Self-compassion, Acceptance and Commitment Therapy and also contains psychoeducation. The group treatment consists of 8 sessions delivered once a week for 2 hrs during 8 weeks in a child- and adolescent psychiatric outpatient setting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-criticism
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
Forms of Self-Criticism and Self-Reassuring Scale (FSCRS; Gilbert et al., 2004)
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptoms of depression
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
Montgomery Åsberg Depression Rating Scale, self-report version (MADRS-S; Montgomery et al., 1979).
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
Symptoms of anxiety
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
Liebowitz Social Anxiety Scale, self-report (LSAS; Liebowitz, 1987)
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
Nonsuicidal self-injury
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
Selected items from Self-Injurious Thoughts and Behaviors interview (SITBI; Nock et al., 2007), Deliberate self-harm inventory (DSHI; Gratz et al., 2001) och Clinician Administered Nonsuicidal self-injury Disorder Interview (CANDI; Gratz et al., 2015)
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
Individually chosen behavior
Time Frame: Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
A behavior driven by self-criticism
Change from baseline (phase A) at intervention (phase B) 8 weeks, and at 3- and 6- months
Self-Compassion
Time Frame: Change from before to after intervention, and at 3- and 6- month follow-up
Self-Compassion Scale, short form (SCS; Raes et al., 2011)
Change from before to after intervention, and at 3- and 6- month follow-up
Psychological flexibility
Time Frame: Change from before to after intervention, and at 3- and 6- month follow-up
Avoidance and Fusion Questionnaire for Youth (AFQ-Y8; Greco et al., 2008).
Change from before to after intervention, and at 3- and 6- month follow-up
Quality of life and functioning
Time Frame: Change from before to after intervention, and at 3- and 6- month follow-up
The Work and Social Adjustment Scale, youth version (WSAS-Y; Mundt et al., 2002).
Change from before to after intervention, and at 3- and 6- month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Zetterqvist, PhD, Region Östergötland and Linköping university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 3, 2021

Primary Completion (Actual)

June 27, 2023

Study Completion (Actual)

June 27, 2023

Study Registration Dates

First Submitted

January 27, 2022

First Submitted That Met QC Criteria

February 9, 2022

First Posted (Actual)

February 18, 2022

Study Record Updates

Last Update Posted (Actual)

October 29, 2024

Last Update Submitted That Met QC Criteria

October 25, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Treating self-criticism

Subscribe